Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Evaluating Bronchodilator Response in Patients With Bronchiectasis

NCT05932316 is registered in ClinicalTrials.gov with Rambam Health Care Campus as lead sponsor.

NCT NCT05932316
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05932316 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Evaluating Bronchodilator Response in Patients With Bronchiectasis
Lead sponsor
Rambam Health Care Campus
Phase
Not applicable
Overall status
Unknown status
Start date
May 20, 2023
Completion date
December 31, 2024
Enrollment
96 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

bronchiectasis, bronchiolitis obliterans, cystic fibrosis, primary ciliary dyskinesia, primary immune deficiency